Gamelin Erick - Insider Non-Derivative Transactions at Acrivon Therapeutics, Inc. (ACRV) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Nov 14, 2025, Gamelin Erick's relationship to Acrivon Therapeutics, Inc. (ACRV) is Officer (Chief Development Officer), and currently has 15,283 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ACRV insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Gamelin Erick - Insider Non-Derivative Transactions of ACRV Common Stock

Gamelin Erick - Insider Non-Derivative Transactions at ACRV

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Nov 15, 2025	F -- (Common Stock)	403	2.24	15283
Aug 15, 2025	F -- (Common Stock)	403	1.39	15686
May 15, 2025	F -- (Common Stock)	403	1.14	16089
Feb 15, 2025	F -- (Common Stock)	469	5.42	16492
Nov 15, 2024	F -- (Common Stock)	402	7.92	16961
Aug 15, 2024	F -- (Common Stock)	402	7.02	17363
May 15, 2024	F -- (Common Stock)	402	8.36	17765
Feb 15, 2024	F -- (Common Stock)	468	3.4	18167
Nov 15, 2023	F -- (Common Stock)	1395	5.08	18635